In Becerra, an HHS Nominee With Political Skill But No Front-Line Health Experience
Despite his lack of front-line experience, Democrats see the California attorney general as an important ally to shepherd a progressive agenda on the Affordable Care Act, Medicaid, reproductive health services and immigration.
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
Nursing Homes Still See Dangerously Long Waits for COVID Test Results
The Trump administration hailed rapid tests as the way to halt COVID’s spread in nursing homes. A KHN analysis of federal data shows they’re not being used, as questions linger about accuracy and best practices.
As Nation Awaits Vaccine, Biden Is Under Pressure to Name New FDA Chief ASAP
It typically takes months to install new leadership, but with COVID deaths set to surge through the winter, many Democrats say Biden doesn’t have that sort of time.
Verily’s COVID Testing Program Halted in San Francisco and Oakland
Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
Inside the Flawed White House Testing Scheme That Did Not Protect Trump
President Trump relied heavily on testing as protection against COVID exposure, eschewing masks and social distancing.
El sistema de pruebas para COVID de la Casa Blanca no protegió al presidente
El diagnóstico de COVID-19 del presidente Donald Trump está generando nuevas preguntas sobre la estrategia de la Casa Blanca para realizar pruebas y contener la propagación del virus.
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
It’s Not Just Insulin: Lawmakers Focus on Price of One Drug, While Others Rise Too
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
Lack of Antigen Test Reporting Leaves Country ‘Blind to the Pandemic’
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Trump Is Sending Fast, Cheap COVID Tests to Nursing Homes — But There’s a Hitch
Experts say the administration’s approach with antigen tests could add cost and risk for the most vulnerable patients.
As Georgia Reopened, Officials Knew of Severe Shortage of PPE for Health Workers
State officials said they urgently needed millions more masks and gowns, internal emails show. At least 80 Georgia health workers have died from COVID-19, including after the state reopened its economy.
Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout Anyway.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.
White House Left States On Their Own To Buy Ventilators. Inside Their Mad Scramble.
Although laws prohibit price gouging on precious resources in times of emergency, states have been forced to compete for a share of the nation’s stockpile of ventilators — used to treat the sickest COVID patients — or pay top dollar on sideline deals. With quality and quantity control lacking, what happens when the pandemic’s second wave hits?
COVID Bailout Cash Goes To Big Players That Have Paid Millions To Settle Allegations Of Wrongdoing
At least half of the top 10 recipients, part of a group that received $20 billion in emergency HHS funding, have paid criminal penalties or settled charges related to improper billing and other practices.
Abbott’s Fast COVID Test Poses Safety Issues, Lab Workers Say
HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.
The COVID-19 Bailout That’s Left Every Hospital Unhappy In Its Own Way
Despite intense lobbying for a piece of the $100 billion bailout pot, big New York hospitals and rural systems alike say they aren’t getting a fair share.
Trump Touted Abbott’s Quick COVID-19 Test. HHS Document Shows Only 5,500 Are On Way For Entire U.S.
States urgently need millions of tests, and the game changer they’ve been waiting on falls well short of what is needed, according to government documents obtained by KHN.
‘Red Dawn Breaking Bad’: Officials Warned About Safety Gear Shortfall Early On, Emails Show
As President Donald Trump called the nation “in good shape” to handle COVID-19, a cache of emails released by officials in Washington state show that top public health authorities feared gear shortages and doctor safety in the early epicenter of sickness and deaths.
